Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome

We hypothesized that sirolimus, an mTOR inhibitor, may be effective in patients with autoimmune lymphoproliferative syndrome (ALPS) and treated patients who were intolerant to or failed other therapies. Four patients were treated for autoimmune cytopenias; all had a rapid complete or near complete r...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Teachey, David T., Greiner, Robert, Seif, Alix, Attiyeh, Edward, Bleesing, Jack, Choi, John, Manno, Catherine, Rappaport, Eric, Schwabe, Dirk, Sheen, Cecilia, Sullivan, Kathleen E., Zhuang, Hongming, Wechsler, Daniel S., Grupp, Stephan A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2009
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2819393/
https://ncbi.nlm.nih.gov/pubmed/19208097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2141.2009.07595.x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky